Lonza boosts biologics in New Hampshire

by Rick Mullin
May 13, 2018 | APPEARED IN VOLUME 96, ISSUE 20


Lonza will expand its Portsmouth, N.H., biologics manufacturing site with the addition of multiple 6,000-L bioreactors for mammalian cell production as well as cell therapy suites that can handle projects from Phase I through commercial-scale manufacturing. The new facilities will employ single-use bioreactor technology. Lonza, an early entrant into contract biologics manufacturing, has operated the Portsmouth plant since the late 1990s.


This article has been sent to the following recipient:

Leave A Comment

*Required to comment